Of interest, SLC26A4 is increased in AT2 cells and serum of asthmatic patients and is associated with lung function, and inhibition of SLC26A4 promoted epithelial cell TGF-β1 release and attenuated allergic airway information in asthma. Here, SLC26A4 is linked to asthma.